Turbat, Terkhen
Loading...
Товч нэр
Turbat, Terkhen
Бүтэн нэр
Turbat Terkhen
Латин нэр
Turbat Terkhen
Албан тушаал
Судлаач
6 results
Now showing 1 - 6 of 6
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Treatment outcomes of gestational choriocarcinoma before and after EMA/CO introduction in Mongolia: a 15-year retrospective cohort study(2026-08-05) ;Ulziijargal Sukhbat ;Gandolgor Batsuuri ;Eiko Yamamoto; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Maternal Health among the Kazakh people of Bayan-Ölgii province, Mongolia(Springer Science and Business Media LLC, 2023-11-30); ;Habidan, Omirgul; ;Hurmethan, ErkegulKharakhuz, Meiz - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Treatment outcomes of gestational choriocarcinoma before and after EMA/CO introduction in Mongolia: a 15-year retrospective cohort study(2026) ;Sukhbat, Ulziijargal ;Batsuuri, Gandolgor ;Yamamoto, Eiko; OBJECTIVE: To evaluate the clinical characteristics, metastatic patterns, and treatment outcomes of gestational choriocarcinoma in Mongolia, with a particular focus on the impact of etoposide-methotrexate-actinomycin D/cyclophosphamide-vincristine (EMA/CO) chemotherapy implementation. METHODS: A retrospective cohort study was conducted including 66 patients diagnosed with gestational choriocarcinoma between 2011 and 2025. Patients were stratified based on FIGO stage and metastatic status. Clinical features, antecedent pregnancy, and treatment outcomes were analyzed. Comparisons between pre-implementation (2011-2017) and post-implementation (2018-2025) cohorts were performed using independent t-test, chi-square test, or Fisher's exact test as appropriate. RESULTS: Of the 66 patients, 42.4% (n = 28) had non-metastatic disease (FIGO stage I), while 57.6% (n = 38) presented with metastatic disease (FIGO stages II-IV). Vaginal bleeding was the most common presenting symptom (84.8%). The lungs were the most frequent site of metastasis. Following implementation of the EMA/CO chemotherapy regimen in 2018, higher complete remission rates and lower observed mortality were observed in the post-implementation cohort. Complete remission increased from 69.7% (23/33) to 97.0% (32/33) (p = 0.006), while disease-related mortality decreased from 30.3% (10/33) to 3.0% (1/33) (p = 0.006). Chemoresistance and relapse rates also decreased, although these differences were not statistically significant. Additional interventions, including surgery for residual disease and radiotherapy for brain or lung metastases, were applied when indicated. Despite overall improvements, metastatic disease remained a key determinant of prognosis. CONCLUSION: Patients treated after 2018 demonstrated higher complete remission rates and lower observed mortality compared with those treated before 2018. However, due to the retrospective design, absence of adjusted outcome analysis, and baseline differences between treatment-era cohorts, these findings should be interpreted cautiously. Early diagnosis, routine serum β-hCG surveillance, timely referral, and standardized management remain essential for optimizing outcomes in gestational choriocarcinoma. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Facilitators and barriers to compliance with a raw coal ban amongst pregnant women and mothers of young children in Ulaanbaatar, Mongolia: A mixed-methods study(Public Library of Science (PLoS), 2026) ;Miller, Rob ;Dickinson-Craig, Emma ;Harbach, Sophie ;Vickers, CharlesUlaanbaatar, Mongolia, is in the midst of a winter air pollution crisis driven by the combustion of solid fuels in the peri-urban Ger districts to which young children, fetuses and pregnant women are particularly vulnerable. To address this, the Mongolian government banned the sale and use of raw coal in May 2019 and has subsidized and promoted refined coal briquettes as an alternative fuel. This mixed-methods study utilized semi-structured interviews (n = 30) and a questionnaire survey (n = 369) to identify facilitators and barriers to compliance with the ban amongst Mongolian mothers living in Ulaanbaatar. Four main themes were identified that affected compliance: knowledge about air pollution, information sources, initial policy impacts and governance. Facilitators of participants' ban compliance included awareness of the severity of air pollution's health impacts, support for the policy and governmental enforcement. Concerns regarding fuel alternative safety and affordability, as well as uncertainty about the policy itself (inadequate information) were found to be barriers. Incorporation of these insights in future air pollution mitigation strategies could be beneficial for strengthening their effectiveness, both in Mongolia and settings that face similar challenges throughout the world, which in turn could be a crucial step in meeting the 2030 Sustainable Development Goals agenda. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Correction: Treatment outcomes of gestational choriocarcinoma before and after EMA/CO introduction in Mongolia: a 15-year retrospective cohort study(2026) ;Sukhbat, Ulziijargal ;Batsuuri, Gandolgor ;Yamamoto, Eiko; [This corrects the article DOI: 10.3389/fonc.2026.1863040.]. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Improving Air Quality and Childhood Respiratory Health in Mongolia: The Impact of the Raw Coal Ban and COVID-19 Restrictions—An Interrupted Time-Series Analysis(MDPI AG, 2025-01-03) ;Dickinson-Craig, Emma; ;Hemming, Karla ;Pope, Francis D.Bartington, Suzanne E.Scopus© Citations 2
